TECTONIC THERAPEUTIC, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
TECTONIC THERAPEUTIC, INC. (TECX) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$228.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$1.86M, a 182.35% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $1.63M.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $571.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $34.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$552.00K.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$5.64M, a 450.22% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $1.61M.
- TECTONIC THERAPEUTIC, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$3.91M, a 281.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$228.00K 10-Q · filed 2026-08-06 | $343.00K derived: sum of 3 quarters · filed 2026-08-06 | $377.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.63M 10-Q · filed 2026-05-07 | $2.20M derived: sum of 2 quarters · filed 2026-05-07 | $2.24M derived: sum of 3 quarters · filed 2026-05-07 | $4.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $605.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.87M derived: sum of 3 quarters · filed 2026-08-06 | -$552.00K 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.29M derived: sum of 2 quarters · filed 2026-08-06 | -$1.12M 10-Q · filed 2025-11-06 | -$4.31M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.16M 10-Q · filed 2026-08-06 | -$4.35M derived: sum of 3 quarters · filed 2026-08-06 | -$6.95M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$3.42M 10-Q · filed 2026-05-07 | -$6.61M derived: sum of 2 quarters · filed 2026-05-07 | -$9.21M derived: sum of 3 quarters · filed 2026-05-07 | -$10.44M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.79M derived: sum of 2 quarters · filed 2026-02-26 | -$7.02M derived: sum of 3 quarters · filed 2026-02-26 | -$5.64M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.83M derived: sum of 2 quarters · filed 2025-11-06 | -$2.45M 10-Q · filed 2025-11-06 | -$601.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $153.00K 10-Q · filed 2025-08-07 | $2.00M derived: sum of 3 quarters · filed 2025-08-07 | $119.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $1.38M 10-Q · filed 2025-05-08 | -$2.41M 10-Q · filed 2024-05-09 | $3.23M derived: sum of 2 quarters · filed 2025-05-08 | $1.35M derived: sum of 3 quarters · filed 2025-05-08 | $3.64M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$34.00K derived: sum of 2 quarters · filed 2025-03-20 | $2.26M derived: sum of 3 quarters · filed 2025-03-20 | $1.61M 10-K · filed 2025-03-20 | -$6.66M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $412.00K derived: sum of 2 quarters · filed 2024-11-12 | -$239.00K 10-Q · filed 2024-11-12 | -$6.73M 10-Q · filed 2023-11-09 | -$2.84M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.65M 10-Q · filed 2024-08-14 | -$3.39M 10-Q · filed 2023-08-10 | -$956.00K derived: sum of 3 quarters · filed 2024-08-14 | $876.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$651.00K 10-Q · filed 2024-05-09 | -$3.25M derived: sum of 2 quarters · filed 2024-05-09 | -$1.42M derived: sum of 3 quarters · filed 2024-05-09 | -$1.68M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$769.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.03M derived: sum of 3 quarters · filed 2024-03-14 | -$3.91M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.57M derived: sum of 2 quarters · filed 2023-11-09 | -$1.30M 10-Q · filed 2023-11-09 | -$4.72M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$3.14M 10-Q · filed 2023-08-10 | -$6.55M derived: sum of 3 quarters · filed 2023-08-10 | -$1.99M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$2.88M 10-Q · filed 2023-05-11 | -$6.29M derived: sum of 2 quarters · filed 2023-05-11 | -$1.73M derived: sum of 3 quarters · filed 2023-05-11 | $3.09M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.14M derived: sum of 2 quarters · filed 2023-03-23 | $5.97M derived: sum of 3 quarters · filed 2023-03-23 | $2.15M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $9.39M derived: sum of 2 quarters · filed 2022-11-08 | $5.57M 10-Q · filed 2022-11-08 | -$3.38M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.00M 10-Q · filed 2022-08-09 | -$7.94M derived: sum of 3 quarters · filed 2022-08-09 | $1.92M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$3.82M 10-Q · filed 2022-05-10 | -$12.76M derived: sum of 2 quarters · filed 2022-05-10 | -$2.90M derived: sum of 3 quarters · filed 2022-05-10 | -$520.00K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $917.00K derived: sum of 2 quarters · filed 2022-03-17 | $3.30M derived: sum of 3 quarters · filed 2022-03-17 | $3.94M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $9.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $12.24M derived: sum of 2 quarters · filed 2021-11-04 | $12.88M 10-Q · filed 2021-11-04 | $14.22M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.02M 10-Q · filed 2021-08-05 | $4.36M derived: sum of 3 quarters · filed 2021-08-05 | $6.76M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $635.00K 10-Q · filed 2021-05-13 | $1.98M derived: sum of 2 quarters · filed 2021-05-13 | $4.38M derived: sum of 3 quarters · filed 2021-05-13 | $3.98M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $3.74M derived: sum of 2 quarters · filed 2021-03-18 | $3.35M derived: sum of 3 quarters · filed 2021-03-18 | $1.92M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.00M derived: sum of 2 quarters · filed 2020-11-05 | $577.00K 10-Q · filed 2020-11-05 | $4.38M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.82M 10-Q · filed 2020-08-06 | $1.98M derived: sum of 3 quarters · filed 2020-08-06 | $3.59M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$1.43M 10-Q · filed 2020-05-07 | $2.38M derived: sum of 2 quarters · filed 2020-05-07 | $3.98M derived: sum of 3 quarters · filed 2020-05-07 | $3.54M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $5.41M derived: sum of 2 quarters · filed 2020-03-16 | $4.96M derived: sum of 3 quarters · filed 2020-03-16 | $5.31M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.16M derived: sum of 2 quarters · filed 2019-11-07 | $1.51M 10-Q · filed 2019-11-07 | $2.05M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$98.00K 10-Q · filed 2019-08-08 | $447.00K derived: sum of 3 quarters · filed 2019-08-08 | $730.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $352.00K 10-Q · filed 2019-05-13 | $897.00K derived: sum of 2 quarters · filed 2019-05-13 | $1.18M derived: sum of 3 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $828.00K derived: sum of 2 quarters · filed 2019-03-25 | $1.45M 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $909.00K 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | $626.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |